• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带 NBN 突变的女性乳腺癌风险的等位基因修饰。

Allelic modification of breast cancer risk in women with an NBN mutation.

机构信息

Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, 71-252, Poland.

Department of Clinical Genetics and Pathology, University of Zielona Góra, Zielona Góra, Poland.

出版信息

Breast Cancer Res Treat. 2019 Nov;178(2):427-431. doi: 10.1007/s10549-019-05391-w. Epub 2019 Aug 13.

DOI:10.1007/s10549-019-05391-w
PMID:31410679
Abstract

BACKGROUND

NBN 657del5 founder mutation predisposes to breast and prostate cancer. Recently, it has been reported that the pathogenicity of this mutation with regard to prostate cancer risk is modified by a missense variant of the same gene (E185Q).

METHODS

To evaluate the interaction of the 657del5 and E185Q founder alleles of NBN on breast cancer risk in Poland, 4964 women with breast cancer and 6152 controls were genotyped for these two recurrent variants of NBN (657del5 truncating variant and E185Q missense variant).

RESULTS

The NBN 657del5 mutation was detected in 57 of 4964 unselected cases and in 35 of 6152 controls (OR = 2.0, p = 0.001). The E185Q GG genotype was detected in 2167 of 4964 unselected cases and in 2617 of 6152 controls (OR = 1.04, p = 0.3). In carriers of the 657del5 deletion, the elevated cancer risk was restricted to women with the GG genotype of the E185Q variant (OR = 3.6, 95% CI 1.9-6.6; p < 0.0001). Among women with other E185Q genotypes, the OR associated with 657del5 was 1.0 (95% CI 0.5-1.8; p = 0.9). The interaction between the two alleles was statistically significant (homogeneity p = 0.003).

CONCLUSION

In Poland, the pathogenicity of the NBN 657del5 mutation is restricted to women with a homozygous GG genotype of missense variant of the same gene (E185Q). This is the first clear example whereby a moderate penetrance breast cancer gene is impacted by a genetic modifier.

摘要

背景

NBN 657del5 突变是乳腺癌和前列腺癌的致病突变。最近,据报道,该突变对前列腺癌风险的致病性可由同一基因的错义变体(E185Q)修饰。

方法

为了评估 NBN 的 657del5 和 E185Q 突变在波兰乳腺癌风险中的相互作用,对 4964 名乳腺癌患者和 6152 名对照者进行了这两种 NBN 常见变异(657del5 截断变异和 E185Q 错义变异)的基因分型。

结果

在 4964 名未选择的病例中,检测到 57 例 NBN 657del5 突变,在 6152 例对照中,检测到 35 例(OR=2.0,p=0.001)。在 4964 名未选择的病例中,检测到 E185Q GG 基因型 2167 例,在 6152 例对照中,检测到 2617 例(OR=1.04,p=0.3)。在携带 657del5 缺失的患者中,升高的癌症风险仅限于 E185Q 变体 GG 基因型的女性(OR=3.6,95%CI 1.9-6.6;p<0.0001)。在其他 E185Q 基因型的女性中,与 657del5 相关的 OR 为 1.0(95%CI 0.5-1.8;p=0.9)。两个等位基因之间的相互作用具有统计学意义(同质性 p=0.003)。

结论

在波兰,NBN 657del5 突变的致病性仅限于同一基因的错义变体(E185Q)纯合 GG 基因型的女性。这是第一个明确的例子,说明中度外显率的乳腺癌基因受到遗传修饰物的影响。

相似文献

1
Allelic modification of breast cancer risk in women with an NBN mutation.携带 NBN 突变的女性乳腺癌风险的等位基因修饰。
Breast Cancer Res Treat. 2019 Nov;178(2):427-431. doi: 10.1007/s10549-019-05391-w. Epub 2019 Aug 13.
2
Inherited NBN Mutations and Prostate Cancer Risk and Survival.遗传 NBN 突变与前列腺癌风险和生存。
Cancer Res Treat. 2019 Jul;51(3):1180-1187. doi: 10.4143/crt.2018.532. Epub 2018 Dec 13.
3
Cancer risk of heterozygotes with the NBN founder mutation.携带NBN始祖突变的杂合子的癌症风险。
J Natl Cancer Inst. 2007 Dec 19;99(24):1875-80. doi: 10.1093/jnci/djm251. Epub 2007 Dec 11.
4
NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.NBS1基因657del5突变可能仅在俄罗斯乳腺癌病例中占有限比例。
Int J Cancer. 2005 Apr 20;114(4):585-9. doi: 10.1002/ijc.20765.
5
Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.奈梅亨断裂综合征1基因在家族性和散发性前列腺癌中的作用。
Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):935-8. doi: 10.1158/1055-9965.EPI-05-0910.
6
Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland.NBS1基因的种系突变657del5对波兰中部乳腺癌的发病率有显著影响。
Int J Cancer. 2006 Jul 15;119(2):472-5. doi: 10.1002/ijc.21853.
7
The c.657del5 variant in the NBN gene predisposes to pancreatic cancer.NBN基因中的c.657del5变异易引发胰腺癌。
Gene. 2016 Aug 10;587(2):169-72. doi: 10.1016/j.gene.2016.04.056. Epub 2016 May 2.
8
An inherited NBN mutation is associated with poor prognosis prostate cancer.一种遗传性 NBN 突变与预后不良的前列腺癌相关。
Br J Cancer. 2013 Feb 5;108(2):461-8. doi: 10.1038/bjc.2012.486. Epub 2012 Nov 13.
9
Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland.波兰携带NBS1种系突变的杂合子患癌风险增加。
Int J Cancer. 2004 Aug 10;111(1):67-71. doi: 10.1002/ijc.20239.
10
Germline 657del5 mutation in the NBS1 gene in breast cancer patients.乳腺癌患者中NBS1基因的种系657del5突变。
Int J Cancer. 2003 Sep 1;106(3):379-81. doi: 10.1002/ijc.11231.

引用本文的文献

1
Association analysis of germline mutations in CHEK2, PALB2, NBN and RECQL with the risk of ductal carcinoma in situ in Polish women.CHEK2、PALB2、NBN和RECQL基因种系突变与波兰女性导管原位癌风险的关联分析
Hered Cancer Clin Pract. 2025 Aug 6;23(1):19. doi: 10.1186/s13053-025-00320-z.
2
Large Cancer Pedigree Involving Multiple Cancer Genes including Likely Digenic and Lynch Syndrome (LS) and an Instance of Recombinational Rescue from LS.涉及多个癌症基因的大型癌症家系,包括可能的双基因和林奇综合征(LS)以及一例来自LS的重组拯救实例。
Cancers (Basel). 2022 Dec 30;15(1):228. doi: 10.3390/cancers15010228.
3
CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?
CHEK2基因变异与甲状腺乳头状癌:是关联还是巧合?
Hered Cancer Clin Pract. 2022 Jan 31;20(1):5. doi: 10.1186/s13053-022-00211-7.
4
Detecting Variants in the NBN Gene While Testing for Hereditary Breast Cancer: What to Do Next?检测 NBN 基因中的变异体,同时检测遗传性乳腺癌:下一步该怎么做?
Int J Mol Sci. 2021 May 29;22(11):5832. doi: 10.3390/ijms22115832.
5
A Population-Based Study of Genes Previously Implicated in Breast Cancer.基于人群的先前与乳腺癌相关的基因研究。
N Engl J Med. 2021 Feb 4;384(5):440-451. doi: 10.1056/NEJMoa2005936. Epub 2021 Jan 20.
6
DNA Repair Syndromes and Cancer: Insights Into Genetics and Phenotype Patterns.DNA修复综合征与癌症:对遗传学和表型模式的见解
Front Pediatr. 2020 Oct 23;8:570084. doi: 10.3389/fped.2020.570084. eCollection 2020.